The study series consists of three studies with the aim to assess the incidence, prevalence, risk factors, comorbidities and management of patients with alopecia areata in Czech Republic based on the patients and registry of a dermatology clinic of a metropolitan hospital.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The epidemiology of Alopecia areata
Timeframe: 1/1/2011-31/12/2020
The epidemiology of Alopecia areata
Timeframe: 1/10/2020-30/9/2021
Prevalence of atopic and autoimmune conditions in patients with Alopecia Areata
Timeframe: 15/10/2021-14/10/2022
Treatments for alopecia areata
Timeframe: 15/10/2021-14/10/2022
Safety and efficacy of treatments in alopecia areata
Timeframe: 15/10/2021-14/10/2022
Measurement of Thyroid stimulating hormone (TSH)
Timeframe: 15/10/2021-14/10/2022
Measurement of free Thyroxine (fT4)
Timeframe: 15/10/2021-14/10/2022
Measurement of free Triodothyronine (fT3)
Timeframe: 15/10/2021-14/10/2022
Measurement of Thyroid peroxidase autoantibodies (TPOAbs)
Timeframe: 15/10/2021-14/10/2022
Measurement of thyreoglobulin autoantibodies (TgAbs)
Timeframe: 15/10/2021-14/10/2022
Measurement of anti TSH receptor antibodies (TRAbs)
Timeframe: 15/10/2021-14/10/2022
Measurement of Vitamin D levels
Timeframe: 15/10/2021-14/10/2022